PALIPERIDONE PALMITATE - Food and Drug Administration

Manufacturer
Food and Drug Administration
Effective date
2022-03-07
Label type
Indexing - product concept
Version
1
Source
full-release
Hydrated at
2026-06-05 00:20:11

Label at a glance#

ProductPALIPERIDONE PALMITATE
Active ingredientPALIPERIDONE PALMITATE

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
PALIPERIDONE PALMITATER8P8USM8FRACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Erzofri extended-releasePALIPERIDONE PALMITATEShandong Luye Pharmaceutical Co., Ltd.492bf9dd-868e-421a-92db-8cca8973aac12026-03-09Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PALIPERIDONE PALMITATE
INVEGA HAFYERAPALIPERIDONE PALMITATEJanssen Pharmaceuticals, Inc6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b2025-02-18Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PALIPERIDONE PALMITATE
INVEGA SUSTENNAPALIPERIDONE PALMITATEJanssen Pharmaceuticals, Inc.1af14e42-951d-414d-8564-5d5fce1385542025-02-14Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PALIPERIDONE PALMITATE
INVEGA TRINZAPALIPERIDONE PALMITATEJanssen Pharmaceuticals, Incc39e65d7-fa44-4e4c-8b12-a654d3ed0eae2025-02-14Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PALIPERIDONE PALMITATE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.